CLINICAL_TRIALS
trial_result
· 2024-07-23
Clinical Trial Update: Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis [Phase 1]
Summary
Phase 1 results evaluating the clinical effect, safety and tolerability of GSK1070806 in atopic dermatitis have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Dermatitis, Atopic | Phase 1 | Status: COMPLETED | Results posted: 2024-07-23